These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 30367115)
1. The mitochondrial antioxidant SS-31 increases SIRT1 levels and ameliorates inflammation, oxidative stress and leukocyte-endothelium interactions in type 2 diabetes. Escribano-Lopez I; Diaz-Morales N; Iannantuoni F; Lopez-Domenech S; de Marañon AM; Abad-Jimenez Z; Bañuls C; Rovira-Llopis S; Herance JR; Rocha M; Victor VM Sci Rep; 2018 Oct; 8(1):15862. PubMed ID: 30367115 [TBL] [Abstract][Full Text] [Related]
2. The mitochondria-targeted antioxidant MitoQ modulates oxidative stress, inflammation and leukocyte-endothelium interactions in leukocytes isolated from type 2 diabetic patients. Escribano-Lopez I; Diaz-Morales N; Rovira-Llopis S; de Marañon AM; Orden S; Alvarez A; Bañuls C; Rocha M; Murphy MP; Hernandez-Mijares A; Victor VM Redox Biol; 2016 Dec; 10():200-205. PubMed ID: 27810734 [TBL] [Abstract][Full Text] [Related]
3. Low testosterone levels are related to oxidative stress, mitochondrial dysfunction and altered subclinical atherosclerotic markers in type 2 diabetic male patients. Rovira-Llopis S; Bañuls C; de Marañon AM; Diaz-Morales N; Jover A; Garzon S; Rocha M; Victor VM; Hernandez-Mijares A Free Radic Biol Med; 2017 Jul; 108():155-162. PubMed ID: 28359952 [TBL] [Abstract][Full Text] [Related]
4. Does Metformin Protect Diabetic Patients from Oxidative Stress and Leukocyte-Endothelium Interactions? Diaz-Morales N; Rovira-Llopis S; Bañuls C; Lopez-Domenech S; Escribano-Lopez I; Veses S; Jover A; Rocha M; Hernandez-Mijares A; Victor VM Antioxid Redox Signal; 2017 Dec; 27(17):1439-1445. PubMed ID: 28467723 [TBL] [Abstract][Full Text] [Related]
5. Effects of simvastatin, ezetimibe and simvastatin/ezetimibe on mitochondrial function and leukocyte/endothelial cell interactions in patients with hypercholesterolemia. Hernandez-Mijares A; Bañuls C; Rovira-Llopis S; Diaz-Morales N; Escribano-Lopez I; de Pablo C; Alvarez A; Veses S; Rocha M; Victor VM Atherosclerosis; 2016 Apr; 247():40-7. PubMed ID: 26868507 [TBL] [Abstract][Full Text] [Related]
6. Are Mitochondrial Fusion and Fission Impaired in Leukocytes of Type 2 Diabetic Patients? Diaz-Morales N; Rovira-Llopis S; Bañuls C; Escribano-Lopez I; de Marañon AM; Lopez-Domenech S; Orden S; Roldan-Torres I; Alvarez A; Veses S; Jover A; Rocha M; Hernandez-Mijares A; Victor VM Antioxid Redox Signal; 2016 Jul; 25(2):108-15. PubMed ID: 27043041 [TBL] [Abstract][Full Text] [Related]
7. The Mitochondrial Antioxidant SS-31 Modulates Oxidative Stress, Endoplasmic Reticulum Stress, and Autophagy in Type 2 Diabetes. Escribano-López I; de Marañon AM; Iannantuoni F; López-Domènech S; Abad-Jiménez Z; Díaz P; Solá E; Apostolova N; Rocha M; Víctor VM J Clin Med; 2019 Aug; 8(9):. PubMed ID: 31466264 [TBL] [Abstract][Full Text] [Related]
8. Human leukocyte/endothelial cell interactions and mitochondrial dysfunction in type 2 diabetic patients and their association with silent myocardial ischemia. Hernandez-Mijares A; Rocha M; Rovira-Llopis S; Bañuls C; Bellod L; de Pablo C; Alvarez A; Roldan-Torres I; Sola-Izquierdo E; Victor VM Diabetes Care; 2013 Jun; 36(6):1695-702. PubMed ID: 23300290 [TBL] [Abstract][Full Text] [Related]
9. Effects of GLP-1 receptor agonists on mitochondrial function, inflammatory markers and leukocyte-endothelium interactions in type 2 diabetes. Luna-Marco C; de Marañon AM; Hermo-Argibay A; Rodriguez-Hernandez Y; Hermenejildo J; Fernandez-Reyes M; Apostolova N; Vila J; Sola E; Morillas C; Rovira-Llopis S; Rocha M; Victor VM Redox Biol; 2023 Oct; 66():102849. PubMed ID: 37591012 [TBL] [Abstract][Full Text] [Related]
10. Protective effects of Paeoniflorin against AOPP-induced oxidative injury in HUVECs by blocking the ROS-HIF-1α/VEGF pathway. Song S; Xiao X; Guo D; Mo L; Bu C; Ye W; Den Q; Liu S; Yang X Phytomedicine; 2017 Oct; 34():115-126. PubMed ID: 28899493 [TBL] [Abstract][Full Text] [Related]
11. Mitochondrial Alterations and Enhanced Human Leukocyte/Endothelial Cell Interactions in Type 1 Diabetes. Iannantuoni F; M de Marañon A; Abad-Jiménez Z; Canet F; Díaz-Pozo P; López-Domènech S; Morillas C; Rocha M; Víctor VM J Clin Med; 2020 Jul; 9(7):. PubMed ID: 32650465 [TBL] [Abstract][Full Text] [Related]
12. Is glycemic control modulating endoplasmic reticulum stress in leukocytes of type 2 diabetic patients? Rovira-Llopis S; Bañuls C; Apostolova N; Morillas C; Hernandez-Mijares A; Rocha M; Victor VM Antioxid Redox Signal; 2014 Oct; 21(12):1759-65. PubMed ID: 25000244 [TBL] [Abstract][Full Text] [Related]
13. Induction of oxidative stress and human leukocyte/endothelial cell interactions in polycystic ovary syndrome patients with insulin resistance. Victor VM; Rocha M; Bañuls C; Alvarez A; de Pablo C; Sanchez-Serrano M; Gomez M; Hernandez-Mijares A J Clin Endocrinol Metab; 2011 Oct; 96(10):3115-22. PubMed ID: 21778215 [TBL] [Abstract][Full Text] [Related]
14. Insulin Resistance in PCOS Patients Enhances Oxidative Stress and Leukocyte Adhesion: Role of Myeloperoxidase. Victor VM; Rovira-Llopis S; Bañuls C; Diaz-Morales N; Martinez de Marañon A; Rios-Navarro C; Alvarez A; Gomez M; Rocha M; Hernández-Mijares A PLoS One; 2016; 11(3):e0151960. PubMed ID: 27007571 [TBL] [Abstract][Full Text] [Related]
15. Is myeloperoxidase a key component in the ROS-induced vascular damage related to nephropathy in type 2 diabetes? Rovira-Llopis S; Rocha M; Falcon R; de Pablo C; Alvarez A; Jover A; Hernandez-Mijares A; Victor VM Antioxid Redox Signal; 2013 Nov; 19(13):1452-8. PubMed ID: 23521574 [TBL] [Abstract][Full Text] [Related]